Resources Contact Us Home
Binding peptides for carcinoembryonic antigen (CEA)

Image Number 5 for United States Patent #7438890.

The present invention provides binding moieties for CEA, which have a variety of uses wherever detecting, isolating or localizing CEA, and particularly CEA as opposed to cross-reactive antigens such as NCA, is advantageous. Particularly disclosed are synthetic, isolated polypeptides capable of binding CEA, which is overexpressed in adenocarcinomas of endodermally derived digestive system epithelia and fetal colon. Such polypeptides and disclosed derivatives are useful, e.g., as imaging agents for CEA-expressing tumors.

  Recently Added Patents
Circuit board having semiconductor chip embedded therein
Correction information calculating device, image processing apparatus, image display system, and image correcting method
Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
Method and system of extending battery life of a wireless microphone unit
Active pulse blood constituent monitoring
Braided boomerang pet toy
Secure service for enabling communication for calling party when communication service for called party is suspended
  Randomly Featured Patents
Circuit arrangement in a television receiver, provided with a line deflection circuit and a switched supply voltage circuit
Laser cutting system
Chlorofluorocarbon-free flexible polyurethane foams and method of making with blowing efficiency enhancers
Properties of polyolefin blends and their manufactured articles
Anti-fracture fan structure
Close-fitting undergarment for women
Forming fabrics
Rotary game table
Pre-fabricated grain elevator